EUCTR2004-004772-36-CZActive, not recruitingPhase 1
Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 38819 for Org 36286 (corifollitropin alfa)
V Organon0 sitesStarted: June 8, 2006Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
Inclusion Criteria
- •1. Subjects who received at least one dose of either Org 36286 or Puregon®/Follistim® AQ Cartridge in Trial 38819;
- •2. Ongoing pregnancy confirmed by ultrasound at least 10 weeks after embryo transfer in Trial 38819;
- •3. Able and willing to give written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Active, not recruiting
Phase 1
Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 38819 for Org 36286 (corifollitropin alfa)Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) programMedDRA version: 7.1 Level: LLT Classification code 10017399EUCTR2004-004772-36-ESV Organon
Active, not recruiting
Phase 1
Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 38819 for Org 36286 (corifollitropin alfa)EUCTR2004-004772-36-FIV Organon
Active, not recruiting
Not Applicable
Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 107012 for the development of Org 36286 (corifollitropin alfa)Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) programEUCTR2006-003812-23-SEV Organon
Active, not recruiting
Phase 1
Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 38819 for Org 36286 (corifollitropin alfa)Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) programMedDRA version: 7.1 Level: LLT Classification code 10017399EUCTR2004-004772-36-GBV Organon
Active, not recruiting
Phase 1
Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 107012 for the development of Org 36286 (corifollitropin alfa)Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) programEUCTR2006-003812-23-CZV Organon